Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial - Harano, Kenichi; Fossati, Roldano; Pardo, Beatriz; Galli, Francesca; Hudson, Emma; Antill, Yoland; Lee, Chulmin; Rabaglio, Manuela; Heitz, Florian; Kolovetsiou-Kreiner, Vassiliki; Lai, Chyong-Huey; Biagioli, Elena; et al. (Journal Of Gynecologic Oncology, 2025)